Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events

被引:19
作者
Wu, Feitong [1 ,2 ,3 ]
Juonala, Markus [4 ,5 ]
Jacobs Jr, David R. [6 ]
Daniels, Stephen R. [7 ]
Kahonen, Mika [8 ,9 ]
Woo, Jessica G. [10 ,11 ]
Sinaiko, Alan R. [12 ]
Viikari, Jorma S. A. [4 ,5 ]
Bazzano, Lydia A. [13 ]
Burns, Trudy L. [14 ]
Steinberger, Julia [15 ]
Urbina, Elaine M. [11 ,16 ]
Venn, Alison J. [1 ]
Raitakari, Olli T. [17 ,18 ,19 ,20 ,21 ]
Dwyer, Terence [1 ,22 ,23 ]
Magnussen, Costan G. [1 ,2 ,17 ,18 ,19 ]
机构
[1] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia
[2] Baker Heart & Diabet Inst, 75 Commercial Rd, Melbourne, Vic 3004, Australia
[3] Univ Melbourne, Fac Med Dent & Hlth Sci, Baker Dept Cardiometabol Hlth, Melbourne, Vic, Australia
[4] Univ Turku, Dept Med, Turku, Finland
[5] Turku Univ Hosp, Div Med, Turku, Finland
[6] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA
[7] Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA
[8] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland
[9] Tampere Univ Hosp, Dept Clin Physiol, Tampere, Finland
[10] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA
[11] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA
[12] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[13] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA
[14] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA
[15] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA
[16] Cincinnati Childrens Hosp Med Ctr, Inst Heart, Cincinnati, OH 45229 USA
[17] Univ Turku, Ctr Populat Hlth Res, Turku, Finland
[18] Turku Univ Hosp, Turku, Finland
[19] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland
[20] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku, Finland
[21] Univ Turku, InFLAMES Res Flagship, Turku, Finland
[22] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford, England
[23] Murdoch Childrens Res Inst, Melbourne, Vic, Australia
基金
英国医学研究理事会; 美国国家卫生研究院; 芬兰科学院; 欧洲研究理事会;
关键词
atherosclerosis; epidemiology; lipoproteins; longitudinal studies; risk assessment; risk factors; UNITED-STATES; HEART; EXERCISE; ADHERENCE; RISK; GUIDELINES; CHILDREN; OUTCOMES; UTILITY; YOUTH;
D O I
10.1161/CIRCULATIONAHA.123.064296
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Although low-density lipoprotein cholesterol (LDL-C) remains the primary cholesterol target in clinical practice in children and adults, non-high-density lipoprotein cholesterol (non-HDL- C) has been suggested as a more accurate measure of atherosclerotic cardiovascular disease (ASCVD) risk. We examined the associations of childhood non-HDL-C and LDL- C levels with adult ASCVD events and determined whether non-HDL- C has better utility than LDL-C in predicting adult ASCVD events. METHODS: This prospective cohort study included 21 126 participants from the i3C Consortium (International Childhood Cardiovascular Cohorts). Proportional hazards regressions were used to estimate the risk for incident fatal and fatal/nonfatal ASCVD events associated with childhood non-HDL- C and LDL-C levels (age- and sex-specific z scores; concordant/discordant categories defined by guideline-recommended cutoffs), adjusted for sex, Black race, cohort, age at and calendar year of child measurement, body mass index, and systolic blood pressure. Predictive utility was determined by the C index. RESULTS: After an average follow-up of 35 years, 153 fatal ASCVD events occurred in 21 126 participants (mean age at childhood visits, 11.9 years), and 352 fatal/nonfatal ASCVD events occurred in a subset of 11 296 participants who could be evaluated for this outcome. Childhood non-HDL-C and LDL-C levels were each associated with higher risk of fatal and fatal/nonfatal ASCVD events (hazard ratio ranged from 1.27 [95% CI, 1.14-1.41] to 1.35 [95% CI, 1.13-1.60] per unit increase in the risk factor z score). Non-HDL-C had better discriminative utility than LDL-C (difference in C index, 0.0054 [95% CI, 0.0006-0.0102] and 0.0038 [95% CI, 0.0008-0.0068] for fatal and fatal/nonfatal events, respectively). The discordant group with elevated non-HDL-C and normal LDL-C had a higher risk of ASCVD events compared with the concordant group with normal non-HDL- C and LDL-C (fatal events: hazard ratio, 1.90 [95% CI, 0.98-3.70]; fatal/nonfatal events: hazard ratio, 1.94 [95% CI, 1.23-3.06]). CONCLUSIONS: Childhood non-HDL-C and LDL-C levels are associated with ASCVD events in midlife. Non-HDL-C is better than LDL-C in predicting adult ASCVD events, particularly among individuals who had normal LDL-C but elevated non-HDL-C. These findings suggest that both non-HDL-C and LDL-C are useful in identifying children at higher risk of ASCVD events, but non-HDL-C may provide added prognostic information when it is discordantly higher than the corresponding LDL-C and has the practical advantage of being determined without a fasting sample.
引用
收藏
页码:217 / 226
页数:10
相关论文
共 50 条
  • [21] Discordance analysis and the Gordian Knot of LDL and non-HDL cholesterol versus apoB
    Sniderman, Allan D.
    Lamarche, Benoit
    Contois, John H.
    de Graaf, Jacqueline
    CURRENT OPINION IN LIPIDOLOGY, 2014, 25 (06) : 461 - 467
  • [22] Age-and sex-specific reference intervals of total cholesterol, LDL cholesterol, HDL cholesterol and non-HDL cholesterol. Comparison of two algorithms for the indirect estimation of reference intervals
    Haeckel, Rainer
    Ammer, Tatjana
    Wosniok, Werner
    Krebs, Alexander
    Torge, Antje
    Oezcueruemez, Mustafa
    Bertram, Alexander
    JOURNAL OF LABORATORY MEDICINE, 2023, 47 (02) : 55 - 62
  • [23] Trajectories of Non-HDL Cholesterol Across Midlife Implications for Cardiovascular Prevention
    Pencina, Karol M.
    Thanassoulis, George
    Wilkins, John T.
    Vasan, Ramachandran S.
    Navar, Ann Marie
    Peterson, Eric D.
    Pencina, Michael J.
    Sniderman, Allan D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (01) : 70 - 79
  • [24] A Retrospective Analysis of Non-HDL Cholesterol: For Improved Cardiovascular Risk Assessment
    Khan, Sohail Rafi
    Mukhtar, Ana
    Ahmed, Altaf
    ANNALS ABBASI SHAHEED HOSPITAL & KARACHI MEDICAL & DENTAL COLLEGE, 2015, 20 (02): : 97 - 102
  • [25] Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients
    Johannesen, Camilla Ditlev Lindhardt
    Mortensen, Martin Bodtker
    Langsted, Anne
    Nordestgaard, Borge Gronne
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (11) : 1439 - 1450
  • [26] Family history of cardiovascular disease and non-HDL cholesterol in prepubescent non-obese children
    Louzada Strufaldi, Maria Wany
    Suano de Souza, Fabiola Isabel
    Puccini, Rosana Fiorini
    Pinho Franco, Maria do Carmo
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2016, 62 (04): : 347 - 352
  • [27] Non-HDL Cholesterol is a More Superior Predictor of Small-Dense LDL Cholesterol than LDL Cholesterol in Japanese Subjects with TG Levels <400 mg/dL
    Moriyama, Kengo
    Takahashi, Eiko
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2016, 23 (09) : 1126 - 1137
  • [28] Non-HDL cholesterol is an independent predictor of long-term cardiovascular events in patients with dyslipidemia after renal transplantation
    Karabulut, Umut
    Cakir, Ulkem
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (09)
  • [29] AN IMPROVED EVALUATION OF THE CARDIOVASCULAR (CVD) RISK IN THE NON-HDL CHOLESTEROL RETROSPECTIVE ANALYSIS
    Taha, Hassan
    Hussain, Adil
    Hussain, Nasir
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (09): : 8625 - 8629
  • [30] Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals
    Orakzai, Sarwar H.
    Nasir, Khurram
    Blaha, Michael
    Blumenthal, Roger S.
    Raggi, Paolo
    ATHEROSCLEROSIS, 2009, 202 (01) : 289 - 295